Abbott Laboratories director Kevin T. Conroy was granted 2,286 restricted stock units under the company's 2026 Incentive Stock Program. This award is ...
ABBOTT LABORATORIES director Daniel J. Starks increased his holdings through an open-market purchase of 10,000 common shares at $92.6537 each and rece...
Bullish
Abbott Laboratories director Daniel J. Starks recently purchased 10,000 common shares totaling $926,537 and received a grant of 2,286 restricted stock...
Bullish
The Point of Care Diagnostics Market is projected to reach US$ 88.83 billion by 2031, growing at a CAGR of 13.0% from US$ 37.93 billion in 2024. This ...
Bullish
Abbott Laboratories (ABT) has experienced a significant share price pullback, declining 5.9% in the last 7 days and 13.1% over the past month, with a ...
ABBOTT LABORATORIES disclosed $1,410,000 in lobbying expenditures for Q1 2026, covering issues such as tax reform, food safety, pension benefits, tari...
Neutral
Abbott Laboratories has reached a preliminary settlement in shareholder derivative lawsuits related to its U.S. infant formula business, alleging inad...
Bullish
Abbott Laboratories successfully defended against a proposed class-action lawsuit alleging its Similac infant formula contained undisclosed heavy meta...
Bullish
Abbott Laboratories has acquired Exact Sciences for $21 billion, a move that significantly expands Abbott's presence in colorectal cancer screening an...
Bearish
A Chicago jury ordered Abbott Laboratories to pay $70 million in damages to four mothers who claimed the company concealed risks associated with its p...
Bearish
A Cook County jury has awarded a total of $70 million in damages against Abbott Laboratories in four cases alleging its infant formula for premature b...